News
Appointment of seven recognized experts is validating for Ventyx’s NLRP3 Program AD/PD™ 2025 provides helpful insights on potential next steps in Parkinson’s disease SAN DIEGO, April 01 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback